Search
for
Sort by
Research 601–630 of 1000+
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- The Effect of Social Support on the Empowerment Status and Alopecia‐Related Quality of Life in Breast Cancer Patients: A Cross‐Sectional Structural Equation Modeling Study
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- The use of hair cortisol for the assessment of stress in animals
- Coreopsis tinctoria Nutt. As a New Raw Material for Natural Hair Coloration: Discovering the Dyeing Potential of Chalcones
- Understanding the Association Between Mental Health and Hair Loss
- Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation
- Decision letter: The signaling lipid sphingosine 1-phosphate regulates mechanical pain
- Telogen Effluvium: Is There a Need for a New Classification
- Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients
- Hox in hair growth and development
- Valorization of Unconventional Hair Waste: Unlocking Opportunities in Materials and Chemical Engineering
- Decision letter: Role of distinct fibroblast lineages and immune cells in dermal repair following UV radiation-induced tissue damage
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Effects of Lavender and Geranium Scalp Hair Cosmetic Scent on Brain Waves
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- Janus Kinase inhibitors in dermatology: a review
- Placental Extracts, Proteins, and Hydrolyzed Proteins as Active Ingredients in Cosmetic Preparations for Hair Loss: A Systematic Review of Available Clinical Evidence
- Health Messages
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study
- Ottawa, Ontario, Canada, February 13–16, 2013
- The Role of Janus Kinase Inhibitors in Dermatology
- Molecular characterization of xerosis cutis: A systematic review